References
- CromptonGK1982Problems patients have using pressurized aerosol inhalersEur J Respir DisSuppl 1191014
- DolovichMRuffinRE1981Optimal delivery of aerosols from metered dose inhalersChest806 Suppl91157307637
- EpsteinSWManningCP1979Survey of the clinical use of pressurized aerosol inhalersCan Med Assoc J1208136427689
- GiraudVRocheN2002Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stabilityEur Respir J192465111866004
- HäussermannSAcerbiD2007Lung deposition of formoterol HFA (Atimos/Forair) in healthy volunteers, asthmatic and COPD patientsJ Aerosol Med203314117894539
- HochrainerDHolzH2005Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalersJ Aerosol Med182738216181002
- KassnerFHodderR2004A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat Soft Mist Inhaler in patients with asthma and chronic obstructive pulmonary diseaseDrugs6416718215257628
- KempJPMeltzerEO1990Beta 2 adrenergic agonists – oral or aerosol for the treatment of asthma?J Asthma27149571973417
- KilfeatherSAPonitzHH2004Improved delivery of ipratropium bromide/fenoterol from Respimat Soft Mist Inhaler in patients with COPDRespir Med983879715139567
- LeachCLDavidsonPJ2002Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone: a cross-over study in healthy volunteersChest122510612171824
- LindgrenSBakeB1987Clinical consequences of inadequate inhalation technique in asthma therapyEur J Respir Dis709383817076
- McFaddenERJr1995Improper patient techniques with metered dose inhalers: clinical consequences and solutions to misuseJ Allergy Clin Immunol96278837636071
- MinaiBAMartinJE2004Results of a physician and respiratory therapist collaborative effort to improve long-term metered-dose inhaler technique in a pediatric asthma clinicRespir Care49600515165293
- MolimardMRaherisonC2003Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary careJ Aerosol Med162495414572322
- NewmanSP2005Inhaler treatment options in COPDEur Respir Rev141028
- NewmanSPBrownJ1998Lung deposition of fenoterol and flunisolide delivered using a novel device for inhaled medicines: comparison of RESPIMAT with conventional metered-dose inhalers with and without spacer devicesChest113957639554631
- NewmanSPPaviaD1980Simple instructions for using pressurized aerosol bronchodilatorsJ R Soc Med7377697241435
- NewmanSPPaviaD1981How should a pressurized beta-adrenergic bronchodilator be inhaled?Eur J Respir Dis623216112156
- NewmanSPSteedKP1996Efficient delivery to the lungs of flunisolide aerosol from a new portable handheld multidose nebuliserJ Pharm Sci8596048877887
- NewmanSPWeiszAW1991Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler techniqueThorax4671261750017
- PhippsPRGondarI1989Comparison of planar tomographic gamma scintigraphy to measure the penetration index of inhaled aerosolsAm Rev Respir Dis1391516232786364
- PitcairnGReaderS2005Deposition of corticosteroid aerosol in the human lung by Respimat Soft Mist inhaler compared to deposition by metered dose inhaler or by Turbuhaler dry powder inhalerJ Aerosol Med182647216181001
- PitcairnGRNewmanSP1997Tissue attenuation corrections in gamma scintigraphyJ Aerosol Med1018798
- SnellNJCGandertonD1999Assessing lung deposition of inhaled medicationsRespir Med931233310464864
- VinckenW2008Clinical efficacy and safety of the combination of ipratropium bromide and fenoterol inhaled via Respimat Soft Mist inhaler for relief of airflow obstructionExpert Rev Resp Med21226
- von BergAJeenaPM2004Efficacy and safety of ipratropium bromide plus fenoterol inhaled via Respimat Soft Mist Inhaler vs a conventional metered dose inhaler plus spacer in children with asthmaPediatr Pulmonol372647214966821